MaxCyte Appoints Douglas Swirsky as Chief Financial Officer

March 27, 2023

https://www.globenewswire.com/news-release/2023/03/27/2635221/0/en/MaxCyte-Appoints-Douglas-Swirsky-as-Chief-Financial-Officer.html

ROCKVILLE, Md., March 27, 2023 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq:MXCT; LSE:MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced Douglas J. Swirsky has been appointed as the Company’s Chief Financial Officer, effective immediately. Mr. Swirsky is a seasoned financial leader with over two decades of experience in the healthcare sector, including as a public company executive at Nasdaq-listed organizations.

Read more at globenewswire.com

Related news for (MXCT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.